BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12120238)

  • 21. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.
    Liede A; Karlan BY; Narod SA
    J Clin Oncol; 2004 Feb; 22(4):735-42. PubMed ID: 14966099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low incidence of BRCA2 mutations in breast carcinoma and other cancers.
    Teng DH; Bogden R; Mitchell J; Baumgard M; Bell R; Berry S; Davis T; Ha PC; Kehrer R; Jammulapati S; Chen Q; Offit K; Skolnick MH; Tavtigian SV; Jhanwar S; Swedlund B; Wong AK; Kamb A
    Nat Genet; 1996 Jun; 13(2):241-4. PubMed ID: 8640236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group.
    Cho JH; Bang S; Park SW; Chung JB; Song SY
    Pancreas; 2008 May; 36(4):337-40. PubMed ID: 18437078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PALB2 analysis in BRCA2-like families.
    Adank MA; van Mil SE; Gille JJ; Waisfisz Q; Meijers-Heijboer H
    Breast Cancer Res Treat; 2011 Jun; 127(2):357-62. PubMed ID: 20582465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inherited predisposition to breast cancer: after the BRCA1 and BRCA2 genes, what next?].
    Bonadona V; Lasset C
    Bull Cancer; 2003 Jul; 90(7):587-94. PubMed ID: 12957799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in Italy.
    Ghiorzo P; Gargiulo S; Nasti S; Pastorino L; Battistuzzi L; Bruno W; Bonelli L; Taveggia P; Pugliese V; Borgonovo G; Mastracci L; Fornarini G; Romagnoli P; Iiritano E; Savarino V; Bianchi-ScarrĂ  G
    J Clin Oncol; 2007 Nov; 25(33):5336-7; author reply 5337-8. PubMed ID: 18024887
    [No Abstract]   [Full Text] [Related]  

  • 27. Progress in cancer genetics: lessons from pancreatic cancer.
    Goggins M; Kern SE; Offerhaus JA; Hruban RH
    Ann Oncol; 1999; 10 Suppl 4():4-8. PubMed ID: 10436774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene-environment interactions in pancreatic cancer.
    Malats N
    Pancreatology; 2001; 1(5):472-6. PubMed ID: 12120227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candidate DNA repair susceptibility genes identified by exome sequencing in high-risk pancreatic cancer.
    Smith AL; Alirezaie N; Connor A; Chan-Seng-Yue M; Grant R; Selander I; Bascuñana C; Borgida A; Hall A; Whelan T; Holter S; McPherson T; Cleary S; Petersen GM; Omeroglu A; Saloustros E; McPherson J; Stein LD; Foulkes WD; Majewski J; Gallinger S; Zogopoulos G
    Cancer Lett; 2016 Jan; 370(2):302-12. PubMed ID: 26546047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recent advances of pancreatic cancer].
    Wang WZ; Liang ZY; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):53-5. PubMed ID: 17374240
    [No Abstract]   [Full Text] [Related]  

  • 31. Study Reveals Genetics of Pancreatic Cancer.
    Cancer Discov; 2018 Sep; 8(9):1054. PubMed ID: 30002082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of pancreatic cancer and implications for therapy.
    Bhosale P; Cox V; Faria S; Javadi S; Viswanathan C; Koay E; Tamm E
    Abdom Radiol (NY); 2018 Feb; 43(2):404-414. PubMed ID: 29177925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of familial pancreatic cancer and its precursors.
    Hruban RH; Canto MI; Griffin C; Kern SE; Klein AP; Laheru D; Yeo CJ
    Curr Treat Options Gastroenterol; 2005 Oct; 8(5):365-75. PubMed ID: 16162302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Driver mutations: a roadmap for getting close and personal in pancreatic cancer.
    Korc M
    Cancer Biol Ther; 2010 Sep; 10(6):588-91. PubMed ID: 20716952
    [No Abstract]   [Full Text] [Related]  

  • 35. Familial pancreatic-cancer gene found.
    Bradbury J
    Lancet Oncol; 2007 Jan; 8(1):14. PubMed ID: 17348120
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetics and pancreatic cancer.
    Lynch HT
    Arch Surg; 1994 Mar; 129(3):266-8. PubMed ID: 8129601
    [No Abstract]   [Full Text] [Related]  

  • 37. Medical genetic study of eight pancreatic cancer-prone families.
    Lynch HT; Fusaro L; Smyrk TC; Watson P; Lanspa S; Lynch JF
    Cancer Invest; 1995; 13(2):141-9. PubMed ID: 7874567
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetics of pancreatic cancer.
    Ahlgren JD
    Cancer Invest; 2001; 19(1):98-9. PubMed ID: 11291563
    [No Abstract]   [Full Text] [Related]  

  • 39. [Report from the 16th Tokai chapter educational seminar: genetic disorders in internal medicine].
    Ishizuka T; Fukuzawa Y; Tanaka F; Nomura S; Horikawa Y; Matsubayashi H; Hozumi I
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):1001-9. PubMed ID: 23772520
    [No Abstract]   [Full Text] [Related]  

  • 40. Germline mutations in pancreatic cancer become better defined.
    Barton MK
    CA Cancer J Clin; 2016; 66(2):93-4. PubMed ID: 26755078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.